This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis
Journal of Clinical Bioinformatics Open Access 28 April 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osborne, R. First novel anti-tuberculosis drug in 40 years. Nat Biotechnol 31, 89–90 (2013). https://doi.org/10.1038/nbt0213-89
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0213-89
This article is cited by
-
Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
Molecular Diversity (2021)
-
Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis
Journal of Clinical Bioinformatics (2015)
-
The Political and Ethical Challenge of Multi-Drug Resistant Tuberculosis
Journal of Bioethical Inquiry (2015)
-
Speculative strategies for new antibacterials: all roads should not lead to Rome
The Journal of Antibiotics (2013)
-
Uridine monophosphate kinase as potential target for tuberculosis: From target to lead identification
Interdisciplinary Sciences: Computational Life Sciences (2013)